Type
1.
Horstick O, Runge-Ranzinger S. Protection of the house against Chagas disease, dengue, leishmaniasis, and lymphatic filariasis: a systematic review. The Lancet. Infectious diseases. 2017;
Type
1.
Streit T, Lafontant JG, Direny A, Addiss D, Milord MD 8Health and Development International, Newburyport, Massachusetts;, Lammie P, et al. Translating research into reality: Elimination of lymphatic filariasis from Haiti. The American journal of tropical medicine and hygiene [Internet]. 2017;97(4_Suppl):71–75. Available from: http://www.ajtmh.org/docserver/fulltext/14761645/97/4_Suppl/tpmd160669.pdf?expires=1508839073&id=id&accname=guest&checksum=5B58BDFAE9F5311FA5E72B7F88FB6E0B
Type
1.
Coutts S, King J, Pa’au M, Fuimaono S, Roth J, King MR, et al. Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration. Tropical medicine and health [Internet]. 2017;45:22. Available from: http://tinyurl.com/ydx66ge8
Type
1.
Mwingira U National Institute for Medical Research (NIMR), Chikawe M, Mandara WL, Mableson H, Uisso C, Mremi I, et al. Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led Mhealth system. PLoS neglected tropical diseases [Internet]. 2017;11(7):e0005748. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005748&type=printable
Type
1.
Barda B, Albonico M, Buonfrate D, Ame S, Ali S, Speich B, et al. Side benefits of mass drug administration for lymphatic filariasis on Strongyloides stercoralis prevalence on Pemba Island, Tanzania. The American journal of tropical medicine and hygiene. 2017;
Type
1.
Dickson B, Graves P, McBride W. Lymphatic filariasis in Mainland Southeast Asia: A systematic review and meta-analysis of prevalence and disease burden. Tropical medicine and infectious disease [Internet]. 2017;2(3). Available from: http://www.mdpi.com/2414-6366/2/3/32/pdf
Type
1.
Eigege A, Evans D, Noland G, Davies E Federal Ministry of Health, Umaru J, Adelamo S, et al. Criteria to stop mass drug administration for Lymphatic filariasis have been achieved throughout Plateau and Nasarawa States, Nigeria. The American journal of tropical medicine and hygiene. 2017;
Type
1.
Martindale, MacKenzie, Mkwanda, Smith, Stanton, Molyneux, et al. “Unseen” Caregivers: The disproportionate gender balance and role of females in the home-based care of lymphatic filariasis patients in Malawi. Frontiers in women’s health [Internet]. 2017;2(2):1-3. Available from: https://oatext.com/pdf/FWH-2-126.pdf
Type
1.
Bardosh K Center for One Health Research, School of Public Health, University of Washington, Seattle, WA 98195, USA, Jean L, Beau De Rochars V, Lemoine J, Okech B, Ryan S, et al. Polisye Kont Moustik: A culturally competent approach to larval source reduction in the context of lymphatic filariasis and malaria elimination in Haiti. Tropical medicine and infectious disease [Internet]. 2017;2(3):39. Available from: http://www.mdpi.com/2414-6366/2/3/39/pdf
Type
1.
Nsakashalo-Senkwe, Mwase, Chizema-Kawesha, Mukonka, Songolo, Masaninga, et al. Significant decline in lymphatic filariasis associated with nationwide scale-up of insecticide treated nets in Zambia. Parasite epidemiology and control [Internet]. 2017; Available from: http://tinyurl.com/y7efmb55
Pagination
- Previous page
- Page 8
- Next page